zika
viru
zikv
associ
seriou
health
condit
intens
search
discov
differ
way
prevent
treat
zikv
infect
underway
berberin
emodin
possess
sever
pharmacolog
properti
shown
particularli
effect
entri
replic
sever
virus
show
emodin
berberin
trigger
virucid
effect
zikv
viru
expos
berberin
reduct
infect
observ
emodin
use
reduct
approxim
dynam
light
scatter
data
show
compound
significantli
reduc
hydrodynam
radiu
viru
particl
solut
report
berberin
emodin
two
natur
compound
strong
virucid
effect
zika
viru
zika
viru
zikv
member
flavivirida
famili
flaviviru
genu
name
forest
first
identifi
approxim
year
minor
epidem
identifi
none
major
consequ
howev
viru
start
circul
brazil
correl
observ
zikv
infect
pregnant
women
poor
fetal
develop
lead
sever
condit
microcephali
neurolog
diseas
although
exact
mechan
zikv
trigger
diseas
still
unclear
relev
inform
avail
exampl
known
viru
penetr
placenta
infect
progenitor
neural
cell
disrupt
develop
addit
fetal
diseas
zikv
also
implic
develop
syndrom
adult
strategi
combat
zikv
infect
includ
develop
vaccin
screen
molecul
inhibit
differ
phase
viral
lifecycl
berberin
isoquinolin
alkaloid
belong
structur
class
protoberberin
encount
mani
plant
includ
berberi
vulgari
exhibit
sever
pharmacolog
properti
particularli
effect
entri
replic
mani
virus
includ
human
cytomegaloviru
hcmv
herp
simplex
viru
hsv
influenza
viru
chikungunya
viru
chikv
alphavirus
emodin
anthraquinon
deriv
also
natur
occur
compound
deriv
chines
herb
rheum
palmatum
polygonum
multiflorum
alo
vera
cassia
obtusifolia
emodin
possess
wide
spectrum
pharmacolog
effect
includ
antivir
activ
coxsaki
viru
human
respiratori
syncyti
viru
hrsv
influenza
viru
epsteinbarr
viru
ebv
herp
simplex
viru
hsv
hepat
b
viru
hbv
japanes
enceph
viru
jev
anoth
flaviviru
studi
test
activ
natur
compound
berberin
emodin
abil
inhibit
zikv
infect
stock
solut
emodin
berberin
dilut
dimethyl
sulfoxid
dmso
sigmaaldrich
st
loui
mo
usa
work
solut
obtain
dilut
differ
concentr
drug
dulbecco
modifi
eagl
medium
dmem
sigmaaldrich
st
loui
mo
usa
vero
cell
atcc
tm
donat
dr
lacerda
nogueira
cultur
dmem
supplement
fetal
bovin
serum
cutlab
campina
brazil
uml
penicillin
streptomycin
invitrogen
new
york
ny
usa
maintain
humidifi
co
incub
c
test
inhibitori
potenti
berberin
emodin
brazilian
zika
viru
strain
isol
febril
patient
northeast
brazil
use
aliquot
viru
inocul
onto
aed
albopictu
mosquito
cell
clone
atcc
incub
leibovitz
medium
cutlab
campina
brazil
supplement
fetal
bovin
serum
uml
penicillin
streptomycin
day
first
cytopath
effect
observ
viral
passag
use
experi
cytotox
berberin
emodin
evalu
order
select
optim
nontox
concentr
compound
vero
cell
assay
vero
cell
seed
well
plate
incub
h
c
media
remov
replac
dmem
contain
differ
concentr
berberin
emodin
effect
compound
cell
analyz
h
h
h
treatment
supernat
remov
solut
bromid
mtt
mgml
sigmaaldrich
st
loui
mo
usa
ad
well
plate
incub
min
c
subsequ
incub
formazan
crystal
solubil
dmso
sigmaaldrich
st
loui
mo
usa
absorb
measur
nm
abil
berberin
emodin
inhibit
zikv
preentri
step
act
directli
viral
particl
test
virucid
assay
briefli
cell
per
well
seed
plate
berberin
emodin
incub
differ
concentr
berberin
emodin
zikv
plaqueform
unit
ml
pfuml
h
c
control
zikv
incub
drug
diluent
dmem
dmso
also
perform
subsequ
drugcontain
supernat
titrat
vero
cell
incub
h
cell
fix
formaldehyd
min
stain
crystal
violet
ethanol
solut
titer
viru
treat
differ
concentr
compound
determin
compar
control
diluent
also
test
influenc
berberin
emodin
cell
receptor
involv
viru
entri
experi
one
day
prior
assay
cellswel
seed
onto
follow
day
cultur
growth
medium
replac
dmem
contain
berberin
emodin
incub
proceed
h
c
one
hour
medium
contain
compound
remov
cell
monolay
wash
thrice
pb
control
incub
dmem
dmso
drug
diluent
treat
cell
infect
zikv
incub
c
h
viru
remov
cultur
media
ad
cell
incub
h
c
co
fixat
formaldehyd
stain
crystal
violet
number
foci
determin
compar
nontreat
control
half
maxim
inhibitori
concentr
ic
half
maxim
cytotox
concentr
cc
berberin
emodin
calcul
use
nonlinear
regress
analysi
ic
cc
valu
use
calcul
select
index
si
compound
si
cc
ic
si
suggest
potenti
effect
higher
valu
promis
drug
dynam
light
scatter
dl
measur
virion
carri
use
freshli
purifi
sampl
zikv
polystyren
curett
optic
path
length
cm
concentr
pfuml
filter
pb
buffer
ph
incub
h
c
absenc
presenc
emodin
berberin
result
present
averag
valu
scan
obtain
zetas
nano
malvern
uk
equip
hene
laser
nm
scatter
light
detect
experiment
data
analyz
use
zetas
softwar
result
viral
inhibit
calcul
percentag
neg
control
medium
plu
drug
diluent
statist
analys
perform
oneway
anova
tukey
posttest
use
graphpad
prism
softwar
graphpad
softwar
san
diego
ca
usa
initi
screen
berberin
emodin
cellular
cytotox
higher
nontox
concentr
berberin
emodin
cell
viabil
experiment
time
figur
nonlinear
regress
analysi
cc
valu
calcul
berberin
emodin
determin
highest
nontox
concentr
compound
virucid
assay
perform
test
abil
compound
impair
viru
particl
infect
supernat
contain
infecti
viru
particl
incub
h
differ
concentr
compound
berberin
emodin
subsequ
use
infect
vero
cell
h
consider
reduct
foci
number
observ
compound
dosedepend
manner
viral
particl
incub
berberin
plaqu
reduc
pfuml
control
pfuml
reduct
zikv
infect
particl
expos
emodin
reduct
approxim
pfuml
pfuml
figur
valu
berberin
emodin
respect
lead
si
berberin
emodin
although
reduc
concentr
berberin
lower
abil
inhibit
viru
test
concentr
berberin
present
signific
reduct
foci
number
compar
control
p
figur
emodin
inhibit
viru
signific
reduct
foci
number
test
concentr
p
except
figur
determin
highest
nontox
concentr
compound
virucid
assay
perform
test
abil
compound
impair
viru
particl
infect
supernat
contain
infecti
viru
particl
incub
h
differ
concentr
compound
berberin
emodin
subsequ
use
infect
vero
cell
h
consider
reduct
foci
number
observ
compound
dosedepend
manner
viral
particl
incub
berberin
plaqu
reduc
pfuml
control
pfuml
reduct
zikv
infect
particl
expos
emodin
reduct
approxim
pfuml
pfuml
figur
ic
valu
berberin
emodin
respect
lead
si
berberin
emodin
although
reduc
concentr
berberin
lower
abil
inhibit
viru
test
concentr
berberin
present
signific
reduct
foci
number
compar
control
p
figur
emodin
inhibit
viru
signific
reduct
foci
number
test
concentr
p
except
figur
final
test
compound
pretreat
expos
cell
compound
prior
infect
vero
cell
incub
berberin
emodin
h
highest
nontox
concentr
prior
zikv
infect
pretreat
berberin
effect
viru
entri
hand
emodin
reduc
entri
plaqu
reduc
pfuml
control
pfuml
figur
hydrodynam
radiu
zikv
determin
incub
berberin
emodin
purifi
zikv
particl
monodispers
red
line
figur
correl
coeffici
close
uniti
supplementari
figur
addit
emodin
final
test
compound
pretreat
expos
cell
compound
prior
infect
vero
cell
incub
berberin
emodin
h
highest
nontox
concentr
prior
zikv
infect
pretreat
berberin
effect
viru
entri
hand
emodin
reduc
entri
plaqu
reduc
pfuml
control
pfuml
figur
final
test
compound
pretreat
expos
cell
compound
prior
infect
vero
cell
incub
berberin
emodin
h
highest
nontox
concentr
prior
zikv
infect
pretreat
berberin
effect
viru
entri
hand
emodin
reduc
entri
plaqu
reduc
pfuml
control
pfuml
figur
hydrodynam
radiu
zikv
determin
incub
berberin
emodin
purifi
zikv
particl
monodispers
red
line
figur
correl
coeffici
close
uniti
supplementari
figur
addit
emodin
hydrodynam
radiu
zikv
determin
incub
berberin
emodin
purifi
zikv
particl
monodispers
red
line
figur
correl
coeffici
close
uniti
supplementari
figur
addit
emodin
green
line
figur
berberin
blue
figur
led
signific
reduct
hydrodynam
radiu
sampl
zikv
incub
emodin
present
sharper
profil
incub
berberin
sinc
drug
dissolv
dmso
dl
measur
also
conduct
dmso
concentr
diluent
indic
signific
differ
nativ
viru
pb
buffer
virus
x
peer
review
green
line
figur
berberin
blue
figur
led
signific
reduct
hydrodynam
radiu
sampl
zikv
incub
emodin
present
sharper
profil
incub
berberin
sinc
drug
dissolv
dmso
dl
measur
also
conduct
dmso
concentr
diluent
indic
signific
differ
nativ
viru
pb
buffer
berberin
emodin
evalu
vitro
virucid
effect
zika
viru
berberin
reduc
viru
infect
almost
vero
cell
compound
present
two
herb
wide
use
natur
therapi
copti
sp
berberi
sp
shown
effect
control
glycemia
lipid
metabol
antimicrobi
point
view
berberin
inhibit
mani
virus
particular
influenza
viru
chikv
hsv
studi
berberin
effect
later
stage
viral
cycl
uncoat
replic
howev
note
virus
mention
flaviviru
emodin
anthraquinon
deriv
present
sever
type
herb
use
primarili
eastern
medicin
treatment
variou
health
condit
compound
also
shown
inhibit
sever
virus
use
differ
mechan
exampl
emodin
block
coronaviru
channel
protein
inhibit
process
viral
particl
releas
cell
compound
also
block
entri
step
coxsackievirus
hsv
also
observ
modest
effect
emodin
pretreat
therefor
interf
viru
entri
howev
mechan
action
clear
previou
studi
effect
emodin
viru
entri
berberin
emodin
evalu
vitro
virucid
effect
zika
viru
berberin
reduc
viru
infect
almost
vero
cell
compound
present
two
herb
wide
use
natur
therapi
copti
sp
berberi
sp
shown
effect
control
glycemia
lipid
metabol
antimicrobi
point
view
berberin
inhibit
mani
virus
particular
influenza
viru
chikv
hsv
studi
berberin
effect
later
stage
viral
cycl
uncoat
replic
howev
note
virus
mention
flaviviru
emodin
anthraquinon
deriv
present
sever
type
herb
use
primarili
eastern
medicin
treatment
variou
health
condit
compound
also
shown
inhibit
sever
virus
use
differ
mechan
exampl
emodin
block
coronaviru
channel
protein
inhibit
process
viral
particl
releas
cell
compound
also
block
entri
step
coxsackievirus
hsv
also
observ
modest
effect
emodin
pretreat
therefor
interf
viru
entri
howev
mechan
action
clear
previou
studi
effect
emodin
viru
entri
determin
high
affin
envelop
phospholipid
bilay
interact
lead
ruptur
destruct
vhsv
viral
particl
wide
spectrum
biolog
activ
describ
emodin
differ
mechan
action
among
directli
relat
induc
chang
viral
envelop
disrupt
herp
simplex
viru
type
envelop
interact
emodin
phospholipid
effect
integr
vesicl
lipid
extract
escherichia
coli
perturb
physic
properti
bilay
report
support
direct
effect
anthraquinon
biolog
membran
berberin
also
describ
act
directli
biomembran
induc
increas
membran
permeabl
dl
measur
indic
differ
estim
hydrodynam
radii
virion
sampl
incub
emodin
berberin
calcul
hydrodynam
diamet
indic
appar
size
dynam
hydratedsolv
particl
includ
hydrat
sphere
encapsul
viru
particl
thu
observ
chang
appar
hydrodynam
radiu
infecti
viral
particl
upon
addit
emodin
berberin
could
indic
disord
disrupt
bilay
alter
solvat
characterist
viral
particl
solut
compound
act
inhibit
viru
attach
host
cell
berberin
emodin
use
prophylact
low
concentr
sinc
number
infecti
particl
primari
infect
rel
low
addit
berberin
also
spread
variou
organ
bodi
liver
kidney
muscl
brain
remain
consider
period
time
desir
characterist
antivir
target
zika
viru
maintain
low
concentr
sinc
mani
cell
line
tissu
shown
permiss
viru
thu
infect
via
mosquito
bite
sexual
contact
could
control
anoth
benefici
featur
berberin
low
toxic
seriou
advers
effect
human
applic
berberin
emodin
encount
obstacl
pharmaceut
develop
poor
aqueou
solubl
rapid
metabol
recent
sever
nanoparticul
deliveri
system
berberin
emodin
report
attempt
address
major
pharmaceut
concern
associ
system
administr
lipidbas
nanocarri
investig
zika
viru
drawn
much
attent
within
scientif
commun
sinc
result
outbreak
brazil
effort
made
identifi
effect
drug
treat
viru
elucid
fundament
characterist
studi
show
berberin
emodin
two
natur
compound
strong
virucid
effect
vitro
directli
impair
zikv
particl
addit
studi
given
high
cellular
viabil
activ
concentr
compound
good
candid
treatment
zika
virusinfect
patient
possibl
prevent
treatment
low
dose
endem
area
